| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$218,184 ) |
| | 2024 | 2022 | PRIME GENOMICS, INC. | 319 BERNARDO AVE | MOUNTAIN VIEW | CA | 94043-5225 | SANTA CLARA | USA | R21CA258013 | Device for Preservation of Cell Free RNA in Saliva | 001 | 2 | NIH | 7/12/2024 | -$218,184 |
| | 2024 | 2022 | PRIME GENOMICS, INC. | 319 BERNARDO AVE | MOUNTAIN VIEW | CA | 94043-5225 | SANTA CLARA | USA | R21CA258013 | Device for Preservation of Cell Free RNA in Saliva | 000 | 2 | NIH | 7/4/2024 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $227,291 ) |
| | 2022 | 2022 | PRIME GENOMICS, INC. | 319 N BERNARDO AVE | MOUNTAIN VIEW | CA | 94043-5225 | SANTA CLARA | USA | R21CA258013 | Device for Preservation of Cell Free RNA in Saliva | 001 | 2 | NIH | 7/18/2022 | $227,752 |
| | 2022 | 2021 | PRIME GENOMICS, INC. | 319 N BERNARDO AVE | MOUNTAIN VIEW | CA | 94043-5225 | SANTA CLARA | USA | R21CA258013 | Device for Preservation of Cell Free RNA in Saliva | 000 | 1 | NIH | 10/18/2021 | $0 |
| | 2022 | 2019 | PRIME GENOMICS, INC. | 319 N BERNARDO AVE | MOUNTAIN VIEW | CA | 94043-5225 | SANTA CLARA | USA | R43CA232952 | A Noninvasive, Precision Medicine Approach to Improve Breast Cancer Screening Using Cell-free RNA from Saliva. | 000 | 1 | NIH | 6/29/2022 | -$461 |
|
| Issue Date FY: 2021 ( Subtotal = $232,400 ) |
| | 2021 | 2021 | PRIME GENOMICS, INC. | 319 N BERNARDO AVE | MOUNTAIN VIEW | CA | 94043-5225 | SANTA CLARA | USA | R21CA258013 | Device for Preservation of Cell Free RNA in Saliva | 000 | 1 | NIH | 6/3/2021 | $232,400 |
|
| Issue Date FY: 2019 ( Subtotal = $300,000 ) |
| | 2019 | 2019 | PRIME GENOMICS, INC. | 250 NATURAL BRIDGES DRIVE | SANTA CRUZ | CA | 95060-5710 | SANTA CRUZ | USA | R43CA232952 | A Noninvasive, Precision Medicine Approach to Improve Breast Cancer Screening Using Cell-free RNA from Saliva. | 000 | 1 | NIH | 4/16/2019 | $300,000 |
|
|
